Innate Pharma to present IPH4102 “TELLOMAK” clinical trial design and preclinical PTCL data at the 2019 ICML

    NEXT STORY
    Global Genetic Testing Markets, 2019-2023 – New Knowledge, Combined with Lower Pricing is Driving the Market
    PREV STORY
    Helsinn to co-support a satellite symposium on current and emerging treatments of Acute Myeloid Leukemia (AML) at 24th European Hematology Association (EHA) Congress
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Bavarian Nordic Introduces New Incentive Programs for Executive Management and Employees

    COPENHAGEN, Denmark, December 8, 2016 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced ...

    author_avatar
    NASDAQ Market News

    Genocea’s GEN-009 Clinical Results Presentation Selected by ASCO’s Journal of Clinical Oncology® as a Top 10 Featured Immuno-oncology Abstract

    author_avatar
    NASDAQ Market News

    Scott Davis Named Chief Executive Officer of HCA Houston Healthcare Northwest

    author_avatar
    NASDAQ Market News